Page last updated: 2024-08-26

fibrinogen and Venous Thrombosis

fibrinogen has been researched along with Venous Thrombosis in 207 studies

Research

Studies (207)

TimeframeStudies, this research(%)All Research%
pre-19908 (3.86)18.7374
1990's10 (4.83)18.2507
2000's89 (43.00)29.6817
2010's70 (33.82)24.3611
2020's30 (14.49)2.80

Authors

AuthorsStudies
Franchini, S; Marcianò, T1
Adelmeijer, J; Bernal, W; Blasi, A; de Haas, RJ; Driever, EG; Fondevila, C; Gregory, S; Heaton, N; Kane, P; Lisman, T; Nagasami, C; Porte, RJ; van den Heuvel, MC; von Meijenfeldt, FA; Weisel, JW; Zen, Y1
Guo, J; Hou, Z; Long, Y; Wang, T; Yin, Y1
Feng, Y; Lei, B; Li, X; Luo, X; Niu, L; Zhang, F; Zhang, H1
He, S; Li, H; Liu, H; Qin, T; Xiao, L; Xu, WL; Zhang, T1
Sang, Y; Wolberg, AS1
Flick, MJ; Francisco, BJ; Mullins, ES; Owens, AP; Palumbo, J; Rosenfeldt, L; Russell, HM; Sharma, BK1
Ge, JP; Gu, JP; He, J; Li, Y; Ma, K; Yin, YY1
Adu, IK; Qi, G; Wu, H; Zheng, D; Zhu, M1
Alfredsson, L; Askling, J; Bang, H; Cornillet, M; Grönwall, C; Hansson, M; Holmdahl, R; Kastbom, A; Klareskog, L; Lundberg, K; Mathsson-Alm, L; Rönnelid, J; Saevarsdottir, S; Serre, G; Skriner, K; Westerlind, H1
Hwang, J; Hwang, SY; Kim, JH; Kim, MS; Koyanagi, A; Lee, MH; Lee, SB; Lee, SW; Park, SH; Shin, JI; Smith, L; Song, TJ; Tizaoui, K; Yon, DK1
Chen, L; Chen, W; Liu, Q; Pan, Y; Peng, Z; Sha, Y; Wang, Y; Wang, Z1
Şimşek, F; Yevgi, R1
Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P1
Asselta, R; Caccia, S; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Stasko, J; Zolkova, J1
Benner, P; Betoule, A; Foucher, S; Gasperini, G; Martinet, C; Muller, P; Renard, A1
Baron, RM; Chen, EC; Cheng, V; Cho, MH; Connell, NT; Connors, JM; Fredenburgh, LE; Moll, M; Sylvester, KW; Woolley, AE; Zon, RL1
Cheng, J; Fu, Z; Song, W; Zhou, L; Zhu, J1
Di Sanza, C; Fish, RJ; Freire, C; Grzegorski, SJ; Neerman-Arbez, M; Richter, CE; Shavit, JA; Vilar, R1
Sharma, M; Surani, S1
Di Sanza, C; Fish, RJ; Garieri, M; Lukowski, SW; Neerman-Arbez, M; Vilar, R1
Pieters, M1
Di Sanza, C; Fish, RJ; Freire, C; Neerman-Arbez, M1
Chen, Y; Wen, H1
Hu, FR; Pan, QY; Tao, HP; Wang, C; Zhao, X1
Bikov, A; Meszaros, M; Schwarz, EI1
Barrett, NA; Benedetti, G; Breen, KA; Camporota, L; Doyle, AJ; Hunt, BJ; Mak, SM; Retter, A; Sanderson, B; Zhang, J1
Bóta, A; Cherpokova, D; Farkas, ÁZ; Farkas, VJ; Feller, T; Kellermayer, MZ; Kiss, B; Kolev, K; Komorowicz, E; Longstaff, C; Sorvillo, N; Szabó, L; Varjú, I; Wacha, A; Wagner, DD1
Ajjan, RA; Ali, M; Ariëns, RAS; Bailey, MA; Baker, SR; Baranauskas, A; Cheah, LT; Connell, SD; Cubbon, RM; Duval, C; Feller, T; McPherson, HR; Naseem, KM; Philippou, H; Raslan, Z; Ridger, VC; Yuldasheva, NY1
Altschul, D; Benton, J; Boehme, AK; Cheng, NT; Dardick, J; Esenwa, C; Fernandez-Torres, J; Flomenbaum, D; Frontera, J; Goldman, I; Holland, R; Ishida, K; Kirchoff-Torres, K; Labovitz, D; Lendaris, A; Liberman, AL; Lord, A; Lu, J; Luna, J; Mabie, P; Malaviya, A; Moncrieffe, K; Patel, N; Seiden, J; Snyder, T; Soetanto, A; Toma, A; Torres, J; Willey, J; Yaghi, S1
Carlsgaard, P; Fareed, J; Finkler, E; Guler, N; Hopkinson, W; Hoppensteadt, D; Liles, J; Wanderling, C1
Gudaityte, R; Kupcinskas, J; Kupcinskiene, K; Macas, A; Maleckas, A; Petereit, R; Trepenaitis, D1
Fujimoto, N; Hasegawa, K; Hasegawa, M; Ito, M; Katayama, N; Matsumoto, T; Nakatani, K; Sudo, A; Wada, H; Wakabayashi, H; Yamada, N; Yamaguchi, T; Yamashita, Y1
Goya, T; Kato, M; Kohjima, M; Mutsuki, T; Ohe, M; Satoh, T; Yamashita, S1
Hudecek, J; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Sokol, J; Stasko, J; Zolkova, J1
Chaubet, F; Collet, JP; Ghebouli, R; Jandrot-Perrus, M; Letourneur, D; Loyau, S; Maire, M; Michel, JB; Saboural, P1
Fan, WL; Liu, BY; Liu, P; Liu, YY; Yin, X; Zhao, JH1
Feng, C; Gao, L; Guo, X; Wang, Q; Wang, Z; Wu, Y; Xing, B; Xu, Z; Yang, Y; Zhang, F1
Wolberg, AS1
Arnold, N; Beutel, ME; Binder, H; Blankenberg, S; Eggebrecht, L; Göbel, S; Jünger, C; Lackner, KJ; Laubert-Reh, D; Münzel, T; Pfeiffer, N; Prochaska, JH; Schulz, A; Spronk, HM; Ten Cate, H; Wild, PS1
Li, L; Long, Y; Xiang, Z; Xing, F1
Meng, X; Wang, B; Wang, Y; Zheng, G1
Guo, L; Qi, Y; Wei, N; Yang, H1
Alvarez-Bollea, MA; Bastos, L; Guglielmone, HA; Jarchum, GD1
Caldwell, SH; Greenberg, CS; O'Leary, JG; Patton, HM1
Bresser, P; Gerdes, VE; Meijers, JC; Oduber, CE; van Beers, EJ; van der Horst, CM1
Asanuma, K; Hasegawa, M; Matsumoto, T; Miyamoto, N; Ohishi, K; Shimokariya, Y; Sudo, A; Uchida, A; Wada, H; Wakabayashi, H; Yamada, N; Yoshida, K1
Cragg, AH; Ehrenwald, E; Gits, CC; Skeik, N1
Chernysh, IN; Crichlow, A; Cuker, A; Ischiropoulos, H; Lightfoot, RT; Martinez, MR; Mills, AM; Nagaswami, C; Weisel, JW1
Absar, S; Ahsan, F; Kwon, YM1
Cini, M; Cosmi, B; Frascaro, M; Legnani, C; Palareti, G; Sartori, M1
Dorđević, V; Miljić, P; Nedeljkov-Jančić, R; Subota, V; Zuvela, M1
Aleman, MM; Byrnes, JR; Walton, BL; Wolberg, AS1
Ariëns, R; Bridge, KI; Philippou, H1
Dresse, MF; Kalenga, M; Lombet, J; Pieltain, C; Rigo, V; Tribolet, S1
Aleman, MM; Byrnes, JR; Degen, JL; Di Paola, J; Flick, MJ; Lam, WA; Mackman, N; Tran, R; Wang, JG; Wolberg, AS1
Bauduer, F1
Feit, J; Hincker, A; Sladen, RN; Wagener, G1
Alhayek, R; Casini, A; de Moerloose, P; Kouteich, KL; Lebreton, A; Neerman-Arbez, M1
Shchukin, SP1
Byrnes, JR; Walton, BL; Wolberg, AS1
Bevelacqua, V; Fenga, C; Guarneri, C; Libra, M; Malaponte, G; Polesel, J; Signorelli, SS; Taborelli, M; Umezawa, K1
Dronkers, CE; Huisman, MV; Klok, FA; van der Hulle, T1
Furukawa, K; Kagawa, S; Kato, A; Kuboki, S; Miyazaki, M; Ohtsuka, M; Okamura, D; Sakai, N; Shimizu, H; Suzuki, D; Takano, S; Takayashiki, T; Yoshitomi, H1
DeRose, G; Dubois, L; Forbes, TL; Istl, A; Kribs, S; Lee, K; Mujoomdar, A; Power, AH; Wiseman, D1
Ariëns, RAS; Bouman, AC; Cheung, YW; McPherson, H; Ten Cate, H; Ten Cate-Hoek, AJ; Ten Wolde, M1
Gao, K; Huang, J; Li, L; Wang, H; Yang, Z; Zhang, J1
Gao, X; Hu, C; Xiao, W; Yang, X; Zhao, H; Zhu, Y1
Bode, C; Hehrlein, C; Hilgendorf, I; Koeck, T; Mischak, H; Peter, K; Reinöhl, J; Rivera, J; Sackmann, C; Schiffer, E; von Zur Mühlen, C; Zirlik, A; Zürbig, P1
Alves, S; Bell, J; Cecil, T; Chandrakumaran, K; Coakes, J; Knight, J; Mohamed, F; Moran, B; Roy, A; Sargant, N; Simpson, S; Wilson, P1
Dong, JY; Huang, W; Luo, MH; Yu, XF; Zhou, CY; Zhu, QH1
Dai, J; Ding, Q; Hu, Y; Liang, Q; Lu, Y; Ouyang, Q; Wang, H; Wang, X; Wu, W; Wu, X; Xie, Y; Zhou, J1
Cheng, ZH; Liu, C; Sun, SQ; Wang, Q; Wang, ZY1
Bohacekova, M; Kaldararova, M; Remkova, A; Simkova, I; Valkovicova, T; Vesely, J1
Hidaka, Y; Kawasaki, T; Suehisa, E; Toku, M1
Marchioro, P; Monica, C; Radu, C; Rossetto, V; Salmaso, L; Simioni, P; Spiezia, L; Tognin, G1
Borel Derlon, A; de Moerloose, P; Gandon-Laloum, S; Le Querrec, A; Neerman-Arbez, M; Robert-Ebadi, H1
Aya, G; Chauleur, C; Cochery-Nouvellon, E; Gris, JC; Lissalde-Lavigne, G; Marès, P; Mercier, E; Mismetti, P1
Jen, H; Shew, S1
Janssen, HL; Jie, KS; Leebeek, FW; Pattynama, PM; Smalberg, JH; Spaander, MV; van Buuren, HR; van den Berg, B1
Hernandez, I; Nowak-Göttl, U; Schulte, T; Seehafer, T; Stoll, M; Thedieck, S; Weiler, H1
Cieśla-Dul, M; Gaweda, B; Rózańska, M; Sadowski, J; Wypasek, E1
Blamey, SL; Burns, P; Carter, DC; Forbes, CD; Lowe, GD; McArdle, BM; Prentice, CR1
Auger, JM; Berny, MA; Bock, PE; Cosemans, JM; Heemskerk, JW; McCarty, OJ; Munnix, IC; Panizzi, P; Schols, SE; Watson, SP1
Hou, LH; Liu, XE; Wang, MF; Yang, LH; Yang, XL; Zhang, RJ1
Raabe, RD1
Baldwin, J; Deatrick, KB; Elfline, M; Henke, PK; Luke, CE; Miller, EM; Sood, V; Upchurch, GR; Wakefield, TW1
Baldwin, JF; Deatrick, KB; Diaz, JA; Elfline, MA; Henke, PK; Hogaboam, C; Kunkel, SL; Luke, CE; Mitsuya, M; Sood, V; Upchurch, GR; Wakefield, TW1
Asami, K; Hayashi, Y; Kaibara, M; Katsumoto, Y; Omori, S; Uchimura, I; Yasuda, A1
Bedi, VS; Mishra, MN1
Lord, ST1
Georgiopoulos, I; Kritikos, E; Laopodis, V; Liasis, L; Ntourakis, D; Papadopoulou, E; Sergentanis, TN; Tzardis, P1
Domagała, TB; Januszek, R; Karkowski, G; Kotula-Horowitz, K; Lelakowski, J; Musiał, J; Piekarz, J; Rydlewska, A1
Bhogaraju, A; Brennan, S; Sarode, R; Shen, YM1
Bembenek, JP; Czlonkowska, A; Karlinski, M; Kobayashi, A1
Preuss, C; Stoll, M1
Hasegawa, M; Matsumoto, T; Nobori, T; Noma, K; Shimokariya, Y; Sudo, A; Uchida, A; Wada, H; Wakabayashi, H; Yamada, N; Yoshida, K1
Domagała, TB; Januszek, R; Kotula Horowitz, K; Lelakowski, J; Majewski, J; Małecka, B; Musiał, J; Rydlewska, A; Ząbek, A1
Cieśla-Dul, M; Drążkiewicz, T; Sadowski, J; Undas, A1
Brzoska, T; Buczko, W; Chlopicki, S; Fedorowicz, A; Grochal, E; Kramkowski, K; Leszczynska, A; Mann, B; Mogielnicki, A; Motterlini, R; Urano, T1
Aispuru, GR; Barousse, AP; Cardone, AJ; Clavier, MM; Gilberto, DO1
Ahluwalia, M; Bo, ZM; Guevara, E; Tun, NM; Villani, GM1
Biesma, DH; Haas, FJ; Kluft, C; Laterveer, RH; Schutgens, RE1
Chen, D; Dai, J; Gu, N; Jiang, Q; Shi, D; Wang, C; Xu, Z; Yang, F1
Benn, M; Klovaite, J; Nordestgaard, BG; Tybjærg-Hansen, A1
Burghardt, S; Giers, G; Handschel, J; Kübler, NR; Naujoks, C1
Darwish Murad, S; de Maat, MP; García-Pagán, JC; Janssen, HL; Koehler, E; Leebeek, FW; Plessier, A; Primignani, M; Rijken, DC; Seijo, S; Smalberg, JH; Trebicka, J; Valla, DC1
Abbate, R; Antonucci, E; Bani, D; Becatti, M; Cellai, AP; Cenci, C; Fiorillo, C; Grifoni, E; Lami, D; Mannini, L; Marcucci, R; Olimpieri, B; Poli, D; Prisco, D1
Brennan, SO; Ho, LL; Zebeljan, D1
van der Bom, JG1
Cichocki, L; Forjanics, A; Gasser, R; Köppel, H; Pilger, E; Renner, W1
Alt, E; Banyai, M; Banyai, S; Koppensteiner, R1
De Staercke, C; Hooper, WC1
Andersen, TO; Groot, PD; Hjeltnes, N; Iversen, PO; Mowinckel, MC; Sandset, PM1
Aleksic, N; Cushman, M; Folsom, AR; Heckbert, SR; Rosamond, WD; Tracy, RP; Tsai, AW1
Dmoszyńska, A; Furmanik, F; Piecuch, W; Sokołowska, B; Walter-Croneck, A1
Abdollahi, M; Cushman, M; Rosendaal, FR1
Blinov, M; Harrington, DJ; Harrington, P; Kapustin, S; Malefora, A; Mitchell, M; Papayan, L; Savidge, GF; Schmeleva, V1
Bernardi, F; Coccheri, S; Ferraresi, P; Gemmati, D; Legnani, C; Lunghi, B; Marchetti, G; Palareti, G; Pinotti, M; Scapoli, C1
Böhles, H; Jacobi, G; Kieslich, M; Lanfermann, H; Porto, L; Schwabe, D1
Bavbek, N; Dagli, M; Kosar, A; Ozturk, M; Sengul, N1
Anthony, JP; Borsa, JJ; Burkart, DJ; Thurlo, SR1
Damico, LA; Fallon, JT; Himber, J; Kirchhofer, D; Nemerson, Y; Riederer, MA; Roux, S; Wohlgensinger, C1
Dmoszyńska, A; Furmanik, F; Piecuch, W; Sokołowska, B1
Kozawa, O; Matsuno, H; Matsuo, O; Okada, K; Ueshima, S1
BOCCHETTI, G; LUCIFERO, A1
Watzke, HH1
HOBBS, JT1
NANSON, EM; PALKO, PD2
FEDORUK, SO; NANSON, EM; PALKO, PD1
DAVIES, JW; HOBBS, JT1
Bałszan-Kowalska, I; Bińczak-Kuleta, A; Chełstowski, K; Ciechanowicz, A; Falkowski, A; Jastrzebska, M1
Franchini, M; Krampera, M; Veneri, D1
Brueckner, S; Eleftheriadis, S; Reinke, U; Roth-Isigkeit, A; Schmucker, P; Siemens, HJ1
Rosendaal, FR; van Hylckama Vlieg, A1
Andersson, J; Bengtsson, AA; Ekdahl, KN; Elgue, G; Nilsson, B; Rönnblom, L; Sturfelt, G1
Fijnheer, R; Probst, K; Rothova, A1
Bastounis, E; Mirilas, P; Papalambros, E; Sigala, F; Travlou, A1
Funai, EF; Hart, D; Kim, E; Lee, MJ; Popiolek, D; Roqué, H; Stephenson, C1
Chen, M; Wu, XM; Yuan, JY; Yuan, XZ; Zhang, SS1
Kajikawa, R; Koga, Y; Oh, J; Sakata, I; Shiokawa, Y; Takasugi, Y; Yamamoto, Y1
Brummel-Ziedins, KE; Mann, KG; Undas, A1
Aillaud, MF; di Minno, G; Eriksson, P; Hamsten, A; Hawe, E; Humphries, S; Juhan-Vague, I; Mannila, MN; Margaglione, M; Mussoni, L; Silveira, A; Tremoli, E; Yudkin, J1
Korte, W; Lämmle, B; Waser, G; Wuillemin, WA1
Camilleri, RS; Cohen, H1
Aznar, J; Calvo, J; Contreras, MT; Corella, D; España, F; Ricart, JM; Todolí, J; Vaya, A1
Rosendaal, FR; Vossen, CY1
Frisbie, JH2
Bossi, F; Bulla, R; Debeus, A; Durigutto, P; Fischetti, F; Macor, P; Meroni, P; Pellis, V; Sblattero, D; Tedesco, F; Ziller, F1
Coffin, R; Droulle, C; Jacotot, T; Leroux, B; Potron, G; Roussel, B1
Bertina, RM; de Visser, MC; Houwing-Duistermaat, JJ; Rosendaal, FR; Uitte de Willige, S; Vos, HL1
Chang, CJ; Hsu, LA; Hsu, TS; Ko, YL; Lee, YS; Teng, MS; Tsai, CT; Wu, S1
Brueck, M; Kramer, W; Rauber, K; Runde, T1
Alonso, A; Díez, N; España, F; Hermida, J; Medina, P; Montes, R; Navarro, S1
Funakoshi, T; Kitao, K; Maruo, T; Morita, H; Moriyama, T; Ohara, N; Yata, A1
Berghold, A; Helwig, U; Schaub, S; Ziervogel, H1
Crist, RA; Flanders, MM; Phansalkar, AR; Roberts, WL; Rodgers, GM1
de Mazancourt, P; de Raucourt, E; Fischer, AM; Meyer, G1
Dörner, T; Hoppe, B; Kiesewetter, H; Salama, A; Tolou, F1
Aléssio, AM; Annichino-Bizzacchi, JM; de Pádua Mansur, A; Höehr, NF; Ozelo, MC; Siqueira, LH1
Dirrigl, A; Eckstein, HH; Heider, P; Metz, S; Zimmermann, A1
Jing, TY; Liu, ZM; Wu, JX; Zhao, XY; Zhao, ZY1
Aun, R; Benabou, JE; Casella, IB; Presti, C; Puech-Leão, P1
Ay, C; Dorda, W; Pabinger, I; Simanek, R; Tengler, T; Vormittag, R; Vukovich, T1
Bertina, RM; De Visser, MC; Rietveld, IM; Uitte de Willige, S; Vos, HL1
Bertina, RM; de Visser, MC; Houwing-Duistermaat, JJ; Rosendaal, FR; van Minkelen, R; Vos, HL1
Grünbacher, G; Köppel, H; Marx-Neuhold, E; März, W; Pilger, E; Renner, W; Wascher, T; Weger, W1
Cornell, A; Cushman, M; Folsom, AR; Polak, J; Tang, Z; Tsai, MY; Wang, L1
Corella, D; España, F; Falcó, C; Ferrando, F; Mira, Y; Simó, M; Todolí, J; Vayá, A1
Duner, E; Fabris, F; Lombardi, AM; Randi, ML; Ruzzon, E; Scandellari, R; Scapin, M; Tezza, F1
Madoiwa, S; Mimuro, J; Miyata, M; Niwa, K; Ohmori, T; Sakata, Y; Sugo, T; Tei, C1
Ames, M; Bramlage, P; Diehm, C; Hoffmanns, P; Hoffmanns, W; Lawall, H; Paar, WD; Pira, A; Rapp, U1
Carbone, S; Griffiths, AB; Hague, WM; Williams, VK1
Doggen, CJ; Pomp, ER; Rosendaal, FR1
Darnige, L; Haberer, JP; Horellou, MH; Meyer, A; Obstler, C; Samama, CM; Szwebel, TA1
Golubykh, VL; Maksimenko, AV; Tischenko, EG1
Hara, A; Kyogashima, M; Onaya, J; Taketomi, T1
Andriamampandry, MD; Cazenave, JP; Freund, M; Gachet, C; Leray, C1
Abgrall, JF; Billon, S; Escoffre-Barbe, M; Ferec, C; Mercier, B1
Bertina, RM; Eikenboom, JC; Kamphuisen, PW; Pablo, R; Rosendaal, FR; Sturk, A; Vos, HL1
Brosstad, F; Kvernebo, K; Laerum, F; Roy, S; Sakariassen, KS1
Ivashchuk, SI1
Dempfle, CE1
Heller, W; Scholpp, J; Schulze, HJ; Schwenzer, N; Wendel, HP1
Grant, PJ; Lane, DA1
Bertina, RM; Rosendaal, FR; van Tilburg, NH1
Light, DR; Morser, J; Nagashima, M; Pagila, R; Verhallen, P; Wang, M; Werner, M; Zhao, L1
Heilmann, L; Hommel, G; Nieman, F; von Tempelhoff, GF1
Ariëns, RA; Carter, AM; Catto, AJ; Grant, PJ; Kohler, HP; Stickland, MH1
Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A1
Austin, H; Dilley, A; Ellingsen, D; Evatt, B; Hooper, WC; Lally, C; Rawlins, P; Silva, V; Wenger, NK; Wideman, C1
Bergelin, RO; Chandler, WC; Manzo, RA; Meissner, MH; Strandness, DE; Zierler, BK1
Goldman, C; Gosselin, R; Lee, SJ; Nguyen, NT; Owings, JT; Pevec, WC; Wolfe, BM1
Mannucci, PM; Tripodi, A1
Hunt, BJ; Kelly, J; Lewis, RR; Rudd, A1
Amorim, S; Arocha-Piñango, CL; Gil San Juan, AG; Guerrero, B; Müller, CA; Perales, J; Pinto, MA1
Booth, NA; Mutch, NJ; Robbie, LA1
Kerr, R; Ludlam, CA; Stirling, D1
Blake, GJ; Lindpaintner, K; Ridker, PM; Schmitz, C1
Arepally, A; Geschwind, JF; Hofmann, LV; Kim, HS; Kirkwood, S; Oechsle, D; Perler, B1
Coccheri, S; Legnani, C; Lunghi, B; Palareti, G; Preda, L; Rossi, E1
Aznar, J; Corella, D; Estellés, A; Ferrando, F; Martínez, M; Mira, Y; Vayá, A; Villa, P1
Shao, M; Wang, J; Wang, M; Wang, Y1
Gaffney, PJ; Mcevoy, FJ; Webbon, PM1
Aznar, J; Contreras, M; Corella, D; España, F; Estelles, A; Ferrando, F; Mira, Y; Vayá, A1

Reviews

23 review(s) available for fibrinogen and Venous Thrombosis

ArticleYear
Risk factors for preoperative deep venous thrombosis in hip fracture patients: a meta-analysis.
    Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology, 2022, Apr-07, Volume: 23, Issue:1

    Topics: Aged; C-Reactive Protein; Dementia; Female; Fibrinogen; Hip Fractures; Humans; Incidence; Retrospective Studies; Risk Factors; Venous Thrombosis

2022
Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
    Arteriosclerosis, thrombosis, and vascular biology, 2022, Volume: 42, Issue:8

    Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thromboembolism; Venous Thrombosis

2022
Efficacy of traditional Chinese medicine combined with rivaroxaban in the treatment of lower extremity deep vein thrombosis: A meta-analysis.
    Medicine, 2022, Sep-30, Volume: 101, Issue:39

    Topics: C-Reactive Protein; Drugs, Chinese Herbal; Fibrinogen; Humans; Lower Extremity; Medicine, Chinese Traditional; Rivaroxaban; Venous Thrombosis

2022
Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:1

    Topics: Cerebral Hemorrhage; ChAdOx1 nCoV-19; Fibrinogen; Humans; Intracranial Thrombosis; Risk Factors; Vaccination; Venous Thrombosis

2023
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
    The Cochrane database of systematic reviews, 2023, 06-05, Volume: 6

    Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial Infarction; Pulmonary Embolism; Stroke; Tranexamic Acid; Transfusion Reaction; Venous Thrombosis

2023
Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19.
    Medicina (Kaunas, Lithuania), 2020, Dec-03, Volume: 56, Issue:12

    Topics: Anticoagulants; Computed Tomography Angiography; COVID-19; Disease Management; Disseminated Intravascular Coagulation; Echocardiography; Extracorporeal Membrane Oxygenation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Partial Thromboplastin Time; Platelet Count; Point-of-Care Systems; Prothrombin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombophilia; Ultrasonography, Doppler, Duplex; Venous Thrombosis; Ventilation-Perfusion Scan

2020
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea.
    International journal of molecular sciences, 2021, Mar-11, Volume: 22, Issue:6

    Topics: Acute Coronary Syndrome; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Fibrinolysis; Gene Expression Regulation; Humans; Hypoxia; Inflammation; Oxidative Stress; Platelet Activation; Platelet Aggregation; Sleep Apnea, Obstructive; Stroke; Venous Thrombosis

2021
Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition.
    Current opinion in hematology, 2018, Volume: 25, Issue:5

    Topics: Animals; Blood Coagulation; Erythrocytes; Factor VIII; Fibrinogen; Humans; Venous Thromboembolism; Venous Thrombosis

2018
AGA Clinical Practice Update: Coagulation in Cirrhosis.
    Gastroenterology, 2019, Volume: 157, Issue:1

    Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Factor Xa Inhibitors; Fibrinogen; Hematocrit; Heparin; Humans; International Normalized Ratio; Liver Cirrhosis; Plasma; Platelet Count; Portal Vein; Thrombelastography; Thrombocytopenia; Thrombophilia; Thrombopoietin; Transfusion Reaction; Venous Thrombosis

2019
Fibrinogen and red blood cells in venous thrombosis.
    Thrombosis research, 2014, Volume: 133 Suppl 1

    Topics: Animals; Blood Coagulation; Erythrocytes; Fibrinogen; Humans; Veins; Venous Thrombosis

2014
Clot properties and cardiovascular disease.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Arterial Occlusive Diseases; Blood Coagulation; Cardiovascular Agents; Cardiovascular Diseases; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Porosity; Venous Thrombosis

2014
Fibrinogen, red blood cells, and factor XIII in venous thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13 Suppl 1

    Topics: Animals; Blood Coagulation; Erythrocytes; Factor XIII; Fibrin; Fibrinogen; Humans; Protein Conformation; Signal Transduction; Structure-Activity Relationship; Venous Thrombosis

2015
Current standings in diagnostic management of acute venous thromboembolism: Still rough around the edges.
    Blood reviews, 2016, Volume: 30, Issue:1

    Topics: Acute Disease; Clinical Decision-Making; Decision Support Techniques; Diagnostic Imaging; Disease Management; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis

2016
Molecular mechanisms affecting fibrin structure and stability.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:3

    Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Protein Conformation; Structure-Activity Relationship; Venous Thrombosis

2011
Inherited risk factors for thrombotic diseases in children: the genome-wide perspective.
    Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:7

    Topics: Adult; Anticoagulants; Child; Drug Resistance; Factor V; Family; Fibrinogen; Genome-Wide Association Study; Humans; Infant, Newborn; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Risk Factors; Stroke; Thrombophilia; Venous Thrombosis

2011
Venous thromboembolism: implications for gene-based diagnosis and technology development.
    Expert review of molecular diagnostics, 2002, Volume: 2, Issue:6

    Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis

2002
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
    Wiener klinische Wochenschrift, 2003, Aug-14, Volume: 115, Issue:13-14

    Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis

2003
Statins and blood coagulation.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:2

    Topics: Animals; Anticholesteremic Agents; Anticoagulants; Arteriosclerosis; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Factor VII; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Biological; Protein Prenylation; Protein Processing, Post-Translational; Staphylococcal Protein A; Thrombin; Thrombomodulin; Thrombophilia; Thromboplastin; Venous Thrombosis

2005
The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:2

    Topics: Acute Disease; Animals; Blood Coagulation; Chronic Disease; Disseminated Intravascular Coagulation; Epitopes; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Thrombophilia; Venous Thrombosis

1999
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
    Blood, 2000, Mar-01, Volume: 95, Issue:5

    Topics: 3' Untranslated Regions; Arterial Occlusive Diseases; Blood Coagulation Factors; Factor V; Factor VII; Factor XIII; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Hemostasis; Humans; Hyperhomocysteinemia; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoproteins; Point Mutation; Polymorphism, Genetic; Prothrombin; Receptors, Cell Surface; Risk Factors; Sequence Deletion; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis

2000
Laboratory investigation of thrombophilia.
    Clinical chemistry, 2001, Volume: 47, Issue:9

    Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis

2001
Screening for subclinical deep-vein thrombosis.
    QJM : monthly journal of the Association of Physicians, 2001, Volume: 94, Issue:10

    Topics: Anticoagulants; Aspirin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Magnetic Resonance Imaging; Patient Selection; Plethysmography; Venous Thrombosis

2001
Interleukin 6 and haemostasis.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Arteriosclerosis; Blood Coagulation Factors; Blood Platelets; Endothelium, Vascular; Factor VIII; Fibrinogen; Hemostasis; Hepatocytes; Humans; Interleukin-6; Leukocytes; Models, Biological; Receptors, Interleukin-6; Thromboplastin; Thrombosis; Venous Thrombosis; von Willebrand Factor

2001

Trials

9 trial(s) available for fibrinogen and Venous Thrombosis

ArticleYear
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2017, Volume: 23, Issue:8

    Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Biomarkers; Carboxypeptidase B2; Female; Fibrinogen; Humans; Male; Middle Aged; Thromboplastin; Venous Thrombosis

2017
Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:6(Special)

    Topics: Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genital Neoplasms, Female; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Laparoscopy; Middle Aged; Postoperative Complications; Prothrombin Time; Treatment Outcome; Venous Thrombosis; Young Adult

2018
Deep venous thrombosis in acute stroke patients.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2012, Volume: 18, Issue:3

    Topics: Acute Disease; Aged; Aged, 80 and over; Brain Ischemia; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Sex Factors; Stroke; Time Factors; Venous Thrombosis

2012
Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.
    International journal of hematology, 2012, Volume: 95, Issue:2

    Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Factor Xa Inhibitors; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fondaparinux; Hemorrhage; Humans; Male; Middle Aged; Polysaccharides; Postoperative Complications; Venous Thrombosis

2012
Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty.
    Journal of clinical anesthesia, 2003, Volume: 15, Issue:6

    Topics: Aged; Aged, 80 and over; Anesthesia, General; Anesthesia, Spinal; Antithrombin III; Arthroplasty, Replacement, Hip; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Platelet Count; Postoperative Complications; Prothrombin; Prothrombin Time; Venous Thrombosis

2003
[Incidence of deep venous thrombosis (DVT) in patients undergoing thoracotomy and changes of hemostasis].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2004, Volume: 36, Issue:5

    Topics: Adult; Aged; Antithrombins; Esophageal Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; International Normalized Ratio; Lung Neoplasms; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen Inactivators; Prospective Studies; Prothrombin Time; Thoracotomy; Venous Thrombosis

2004
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:1

    Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis

2000
Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis.
    Journal of vascular surgery, 2000, Volume: 32, Issue:5

    Topics: Adult; Biomarkers; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Prothrombin; Sensitivity and Specificity; Thrombophlebitis; Venous Thrombosis

2000
Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass.
    Archives of surgery (Chicago, Ill. : 1960), 2001, Volume: 136, Issue:8

    Topics: Adult; Antithrombin III; Bandages; Blood Coagulation Factors; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gastric Bypass; Gravity Suits; Humans; Laparoscopy; Laparotomy; Male; Middle Aged; Peptide Hydrolases; Plasminogen; Protein C; Prothrombin; Venous Thrombosis

2001

Other Studies

175 other study(ies) available for fibrinogen and Venous Thrombosis

ArticleYear
Could a D-dimer/fibrinogen ratio have a role in ruling-out venous thromboembolism?
    Emergency medicine journal : EMJ, 2022, Volume: 39, Issue:12

    Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Prospective Studies; Pulmonary Embolism; Retrospective Studies; Venous Thromboembolism; Venous Thrombosis

2022
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.
    Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:4

    Topics: Anticoagulants; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Thrombosis; Venous Thrombosis; von Willebrand Factor

2022
MicroRNA-136-5p from Endothelial Progenitor Cells-released Extracellular Vesicles Mediates TXNIP to Promote the Dissolution of Deep Venous Thrombosis.
    Shock (Augusta, Ga.), 2022, 05-01, Volume: 57, Issue:5

    Topics: Animals; Antagomirs; Antithrombins; Carrier Proteins; Endothelial Progenitor Cells; Extracellular Vesicles; Fibrinogen; Fibrinolysin; Mice; MicroRNAs; Thioredoxins; Thrombin; Venous Thrombosis

2022
Effect of Early Electroacupuncture Combined with Enhanced Recovery after Surgery (ERAS) on Pain Perception and Dysfunction in Patients after Total Knee Arthroplasty (TKA).
    BioMed research international, 2022, Volume: 2022

    Topics: Arthroplasty, Replacement, Knee; Case-Control Studies; Electroacupuncture; Enhanced Recovery After Surgery; Fibrinogen; Humans; Knee Joint; Osteoarthritis, Knee; Pain; Pain Perception; Postoperative Complications; Range of Motion, Articular; Retrospective Studies; Treatment Outcome; Venous Thrombosis

2022
Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis.
    Blood advances, 2022, 07-26, Volume: 6, Issue:14

    Topics: Child; Fibrinogen; Humans; Liver Diseases; Portal Vein; Venous Thrombosis

2022
The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways.
    Chinese journal of natural medicines, 2022, Volume: 20, Issue:9

    Topics: Animals; Anticoagulants; Catechin; Eosine Yellowish-(YS); Fibrinogen; Hematoxylin; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Polyphenols; Proto-Oncogene Proteins c-akt; Rabbits; Rats; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Tea; Thrombin; Vascular Endothelial Growth Factor A; Venous Thrombosis; Warfarin

2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis.
    Rheumatology (Oxford, England), 2023, 06-01, Volume: 62, Issue:6

    Topics: Arthritis, Rheumatoid; Autoantibodies; Fibrinogen; Humans; Immunoglobulin Isotypes; Immunoglobulin M; Peptides, Cyclic; Rheumatoid Factor; Venous Thromboembolism; Venous Thrombosis

2023
The role of D-dimer and fibrinogen testing in catheter-directed thrombolysis with urokinase for deep venous thrombosis.
    Phlebology, 2023, Volume: 38, Issue:6

    Topics: Catheters; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thrombosis

2023
Assessment of fibrinogen albumin ratio in patients with pregnancy-related cerebral venous thrombosis.
    Acta neurologica Belgica, 2023, Volume: 123, Issue:6

    Topics: Cerebrovascular Disorders; Female; Fibrinogen; Humans; Intracranial Thrombosis; Pregnancy; Retrospective Studies; Risk Factors; Venous Thrombosis

2023
Congenital hypofibrinogenemia associated with a novel heterozygous nonsense mutation in the globular C-terminal domain of the γ-chain (p.Glu275Stop).
    Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:1

    Topics: Afibrinogenemia; Anticoagulants; Blood Coagulation Tests; Codon, Nonsense; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Middle Aged; Recurrence; Thrombelastography; Venous Thrombosis; Warfarin

2020
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
    Journal of thrombosis and thrombolysis, 2020, Volume: 50, Issue:2

    Topics: Arterial Occlusive Diseases; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Decision Support Techniques; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Host-Pathogen Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Organ Dysfunction Scores; Pandemics; Platelet Count; Pneumonia, Viral; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Retrospective Studies; SARS-CoV-2; Thromboembolism; Venous Thrombosis

2020
VTE in ICU Patients With COVID-19.
    Chest, 2020, Volume: 158, Issue:5

    Topics: Adult; Aged; Anticoagulants; Betacoronavirus; C-Reactive Protein; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Enoxaparin; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Incidence; Intensive Care Units; L-Lactate Dehydrogenase; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prothrombin Time; Pulmonary Embolism; SARS-CoV-2; Severity of Illness Index; Ultrasonography; Venous Thromboembolism; Venous Thrombosis

2020
The predictive value of plasminogen activator inhibitor-1, fibrinogen, and D-dimer for deep venous thrombosis following surgery for traumatic lower limb fracture.
    Annals of palliative medicine, 2020, Volume: 9, Issue:5

    Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Plasminogen Activator Inhibitor 1; Retrospective Studies; Venous Thrombosis

2020
A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis.
    Blood advances, 2020, 11-10, Volume: 4, Issue:21

    Topics: Animals; Fibrinogen; Hemostasis; Hemostatics; Venous Thrombosis; Zebrafish

2020
Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.
    Thrombosis and haemostasis, 2021, Volume: 121, Issue:4

    Topics: Animals; Animals, Genetically Modified; Anthralin; Blood Coagulation; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Hep G2 Cells; Hepatocytes; Humans; Integrin alpha2; Morpholinos; Mutation; Oligonucleotides, Antisense; Proteomics; Small Molecule Libraries; Tretinoin; Venous Thrombosis; Zebrafish; Zebrafish Proteins

2021
Small Molecules: A Novel Approach to Alter Fibrinogen Production and Impact Venous Thrombosis.
    Thrombosis and haemostasis, 2021, Volume: 121, Issue:4

    Topics: Fibrinogen; Hemostatics; Humans; Venous Thrombosis

2021
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders.
    International journal of molecular sciences, 2021, Jan-11, Volume: 22, Issue:2

    Topics: Animals; Base Sequence; Biomarkers; Blood Coagulation; Blood Platelets; Disease Models, Animal; Exons; Fibrinogen; Gene Editing; Gene Expression; Plasmids; Platelet Activation; RNA, Guide, Kinetoplastida; Sequence Deletion; Venous Thrombosis; Zebrafish

2021
The predictive value of platelet to lymphocyte ratio and D-dimer to fibrinogen ratio combined with WELLS score on lower extremity deep vein thrombosis in young patients with cerebral hemorrhage.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:9

    Topics: Cerebral Hemorrhage; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lower Extremity; Lymphocytes; Predictive Value of Tests; Retrospective Studies; ROC Curve; Venous Thrombosis

2021
Changes of anti-β2 glycoprotein I antibody IgA/G/M, platelet aggregation rate, plasma fibrinogen and d-dimer in guiding venous thrombosis during pregnancy.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:2

    Topics: Adult; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulins; Platelet Aggregation; Platelet Function Tests; Pregnancy; Venous Thrombosis; Young Adult

2021
A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation.
    Critical care medicine, 2021, 07-01, Volume: 49, Issue:7

    Topics: Adult; C-Reactive Protein; Computed Tomography Angiography; COVID-19; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Intracranial Hemorrhages; London; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; State Medicine; Tertiary Care Centers; Ultrasonography, Doppler; Venous Thromboembolism; Venous Thrombosis

2021
Citrullinated Fibrinogen Renders Clots Mechanically Less Stable, but Lysis-Resistant.
    Circulation research, 2021, 07-09, Volume: 129, Issue:2

    Topics: Animals; Citrullination; Disease Models, Animal; Fibrinogen; Fibrinolysis; Humans; Male; Mice, Inbred C57BL; Microscopy, Atomic Force; Thrombelastography; Venous Thrombosis

2021
Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 07-06, Volume: 118, Issue:27

    Topics: Animals; Blood Coagulation; Blood Platelets; Cross-Linking Reagents; Disease Models, Animal; Factor XIIIa; Fibrinogen; Mice, Inbred C57BL; Optical Imaging; Pulmonary Embolism; Vena Cava, Inferior; Venous Thrombosis

2021
Biomarkers of Coagulation and Inflammation in COVID-19-Associated Ischemic Stroke.
    Stroke, 2021, Volume: 52, Issue:11

    Topics: Aged; Aged, 80 and over; Blood Sedimentation; C-Reactive Protein; Cluster Analysis; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Humans; Inflammation; Interleukin-6; Ischemic Stroke; L-Lactate Dehydrogenase; Leukocyte Count; Logistic Models; Machine Learning; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Pulmonary Embolism; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Venous Thrombosis

2021
Monitoring of Hypercoagulability by Thromboelastography in Bariatric Surgery.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Apr-15, Volume: 23

    Topics: Adult; Bariatric Surgery; Biomarkers; Blood Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Postoperative Period; Predictive Value of Tests; ROC Curve; Thrombelastography; Thrombophilia; Venous Thrombosis

2017
The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:4

    Topics: Aged; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Embolism; Venous Thrombosis

2018
Portal Vein Thrombosis Repeatedly Observed in a Cirrhotic Patient with Antiphospholipid Antibody Syndrome.
    Fukuoka igaku zasshi = Hukuoka acta medica, 2016, Volume: 107, Issue:10

    Topics: Antiphospholipid Syndrome; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Tomography, X-Ray Computed; Venous Thrombosis

2016
Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    International journal of molecular sciences, 2017, Dec-29, Volume: 19, Issue:1

    Topics: Adult; Afibrinogenemia; Base Sequence; Blood Coagulation Tests; Family; Fibrinogen; Fibrinogens, Abnormal; Gene Expression; Hemorrhage; Homozygote; Humans; Male; Middle Aged; Models, Molecular; Mutation; Pedigree; Protein Structure, Secondary; Severity of Illness Index; Venous Thrombosis

2017
Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic Events.
    Thrombosis and haemostasis, 2018, Volume: 118, Issue:1

    Topics: Amines; Animals; Carotid Arteries; Dipeptides; Disease Models, Animal; Fibrinogen; Fibrinolysis; Fucose; Glucose; Humans; Intravital Microscopy; Lysine; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Serum Albumin; Sulfates; Thrombelastography; Thrombosis; Tissue Plasminogen Activator; Venous Thrombosis

2018
Preventive effects of low molecular weight heparin on formation of deep vein thrombosis by reducing D dimer values in patients undergoing spinal surgery.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:1

    Topics: Aged; Aged, 80 and over; Anticoagulants; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Leukocytes; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Venous Thrombosis

2018
Coagulation Alteration and Deep Vein Thrombosis in Brain Tumor Patients During the Perioperative Period.
    World neurosurgery, 2018, Volume: 114

    Topics: Adult; Aged; Biomarkers; Blood Coagulation; Brain Neoplasms; Craniotomy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Perioperative Period; Postoperative Complications; Thrombophilia; Venous Thrombosis

2018
Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.
    Journal of the American Heart Association, 2018, 09-04, Volume: 7, Issue:17

    Topics: Adrenomedullin; Adult; Aged; Ankle Brachial Index; Anticoagulants; Asymptomatic Diseases; Atrial Fibrillation; Atrial Natriuretic Factor; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibrinogen; Germany; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenprocoumon; Protein Precursors; Pulmonary Embolism; Risk Factors; Stroke; Stroke Volume; Vascular Stiffness; Venous Thrombosis; Warfarin

2018
Admission prevalence of deep vein thrombosis in elderly Chinese patients with hip fracture and a new predictor based on risk factors for thrombosis screening.
    BMC musculoskeletal disorders, 2018, Dec-20, Volume: 19, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; China; Decision Support Techniques; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hip Fractures; Humans; Male; Middle Aged; Patient Admission; Phlebography; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Ultrasonography; Venous Thrombosis

2018
The effects of VEGF on deep venous thrombosis in the perioperative period of elderly fracture patients.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:6(Special)

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fractures, Bone; Humans; Male; Perioperative Period; Thrombelastography; Time Factors; Vascular Endothelial Growth Factor A; Venous Thrombosis

2018
Recurrent superficial venous thrombophlebitis because of mutations in the protein C and fibrinogen genes in a young Argentinian female.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:2

    Topics: Afibrinogenemia; Argentina; Female; Fibrinogen; Heterozygote; Humans; Mutation, Missense; Protein C; Recurrence; Sequence Analysis, DNA; Thrombophlebitis; Venous Thrombosis; Young Adult

2019
Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome.
    The Netherlands journal of medicine, 2013, Volume: 71, Issue:5

    Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Infant; Klippel-Trenaunay-Weber Syndrome; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Prothrombin; Pulmonary Embolism; Ultrasonography, Doppler, Duplex; Venous Thromboembolism; Venous Thrombosis; Young Adult

2013
The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.
    Clinica chimica acta; international journal of clinical chemistry, 2013, Oct-21, Volume: 425

    Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Anticoagulants; Arthroplasty, Replacement, Knee; Biomarkers; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fondaparinux; Hemoglobins; Humans; Male; Middle Aged; Polysaccharides; Risk Factors; Venous Thrombosis

2013
Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Vascular and endovascular surgery, 2013, Volume: 47, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Drug Monitoring; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lower Extremity; Male; Middle Aged; Minnesota; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Young Adult

2013
Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
    American journal of physiology. Lung cellular and molecular physiology, 2014, Mar-01, Volume: 306, Issue:5

    Topics: Adult; Aged; Blood Coagulation; Cross-Linking Reagents; Elasticity; Factor XIIIa; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Plasminogen; Prospective Studies; Pulmonary Embolism; Venous Thrombosis

2014
Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis.
    Journal of controlled release : official journal of the Controlled Release Society, 2014, Mar-10, Volume: 177

    Topics: Animals; Fibrinogen; Fibrinolytic Agents; Peptides; Rats; Rats, Sprague-Dawley; Serum Albumin; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis

2014
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units.
    International journal of laboratory hematology, 2014, Volume: 36, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Biological Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Reference Values; Venous Thromboembolism; Venous Thrombosis

2014
Coexistence of hypofibrinogenemia and factor V Leiden mutation: is the balance shifted to thrombosis?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:6

    Topics: Adult; Afibrinogenemia; Factor V; Fibrinogen; Heterozygote; Humans; Male; Point Mutation; Thrombophilia; Venous Thrombosis

2014
[How I explore and treat a neonatal renal vein thrombosis: a case report].
    Revue medicale de Liege, 2014, Volume: 69, Issue:4

    Topics: Adult; Fibrinogen; Hematuria; Humans; Male; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Renal Veins; Thrombocytopenia; Ultrasonography, Doppler; Venous Thrombosis

2014
Factor XIII activity mediates red blood cell retention in venous thrombi.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:8

    Topics: Animals; Blood Coagulation; Disease Models, Animal; Erythrocytes; Factor XIII; Factor XIII Deficiency; Factor XIIIa; Fibrinogen; Homozygote; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mutant Proteins; Mutation; Peptide Fragments; Venous Thrombosis

2014
Is there a significant lower genetic susceptibility to venous thrombosis in the Basques?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2014, Volume: 25, Issue:6

    Topics: ABO Blood-Group System; Alleles; Ethnicity; Factor V; Factor XI; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Spain; Venous Thrombosis; von Willebrand Factor

2014
Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery.
    Critical care (London, England), 2014, Oct-08, Volume: 18, Issue:5

    Topics: Adult; Aged; Female; Fibrinogen; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Predictive Value of Tests; Prospective Studies; ROC Curve; Surgical Procedures, Operative; Thrombelastography; Thromboembolism; Venous Thrombosis

2014
Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2015, Volume: 21, Issue:1

    Topics: Adult; Afibrinogenemia; Female; Fibrinogen; Humans; Pregnancy; Venous Thrombosis

2015
[Modern methods of diagnosis of thrombophylic states and complex treatment of patients with thrombotic complications of severe forms of varicose disease].
    Klinichna khirurhiia, 2014, Issue:11

    Topics: Anticoagulants; Factor V; Factor VII; Factor XII; Female; Fibrinogen; Gene Expression; Genetic Predisposition to Disease; Humans; Integrin alpha2; Integrin beta3; Leg; Male; Middle Aged; Mutation; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Varicose Veins; Venous Thrombosis

2014
Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; Monocytes; Neoplasms; NF-kappa B; Smoking; Thromboplastin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Venous Thrombosis

2015
Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience.
    American journal of surgery, 2015, Volume: 210, Issue:5

    Topics: Abdominal Pain; Anticoagulants; Bile; Female; Fever; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hepatectomy; Humans; Hyperammonemia; Incidence; Liver; Male; Middle Aged; Necrosis; Portal Vein; Retrospective Studies; Risk Factors; Splenectomy; Thrombectomy; Vena Cava, Inferior; Venous Thrombosis

2015
Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Vascular and endovascular surgery, 2015, Volume: 49, Issue:7

    Topics: Arterial Occlusive Diseases; Biomarkers; Catheterization, Peripheral; Down-Regulation; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Punctures; Retrospective Studies; Risk Assessment; Risk Factors; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis

2015
Clot structure and fibrinolytic potential in patients with post thrombotic syndrome.
    Thrombosis research, 2016, Volume: 137

    Topics: Aged; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Postthrombotic Syndrome; Reproducibility of Results; Sensitivity and Specificity; Venous Thrombosis

2016
[Analysis about the high risk factors and prognosis of gynecologic cancer with deep venous thrombosis].
    Zhonghua fu chan ke za zhi, 2015, Volume: 50, Issue:10

    Topics: Body Mass Index; China; Disease-Free Survival; Female; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Humans; Multivariate Analysis; Prognosis; Prothrombin Time; Pulmonary Embolism; Risk Factors; Venous Thrombosis

2015
Impacts of laparoscopic hysterectomy on functions of coagulation and fibrinolysis system.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:4

    Topics: Adult; Blood Coagulation; Carboxypeptidase B2; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hysterectomy; Laparoscopy; Middle Aged; P-Selectin; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Prothrombin Time; Retrospective Studies; Risk; Thrombin Time; Venous Thrombosis; von Willebrand Factor

2016
Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism.
    Proteomics. Clinical applications, 2016, Volume: 10, Issue:5

    Topics: Adult; Aged; Animals; Biomarkers; Case-Control Studies; Collagen Type I; Electrophoresis, Capillary; Female; Fibrinogen; Gene Expression; Humans; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Middle Aged; Osteopontin; Proteome; Pulmonary Embolism; Sensitivity and Specificity; Support Vector Machine; Urinalysis; Venous Thrombosis

2016
A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Transfusion medicine (Oxford, England), 2016, Volume: 26, Issue:2

    Topics: Blood Component Transfusion; Blood Loss, Surgical; Cytoreduction Surgical Procedures; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Tranexamic Acid; Venous Thrombosis

2016
[Clinical significance of monitoring coagulation- and fibrinolysis-related indexes during catheter-directed thrombolysis for acute lower-extremity deep venous thrombosis].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016, Volume: 36, Issue:4

    Topics: Acute Disease; Blood Coagulation; Case-Control Studies; Catheters; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Thrombolytic Therapy; Treatment Outcome; Venous Thrombosis

2016
Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
    Journal of clinical pathology, 2017, Volume: 70, Issue:2

    Topics: Afibrinogenemia; Antiphospholipid Syndrome; China; Fibrin; Fibrinogen; Humans; Male; Mutation; Venous Thrombosis; Young Adult

2017
[Relationship of Serum D-dimer, Fibrinogen, C Reactive Protein and Interleukin 6 with Thrombus Dissolution Volume in Acute Iliac Femoral Vein Thrombosis Model Rats].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:5

    Topics: Acute Disease; Animals; Blood Coagulation; C-Reactive Protein; Femoral Vein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Interleukin-6; Rats; Solubility; Venous Thrombosis

2016
Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification?
    Bratislavske lekarske listy, 2016, Volume: 117, Issue:10

    Topics: Adult; Aged; Anticoagulants; Chronic Disease; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Platelet Count; Prevalence; Pulmonary Embolism; Risk Factors; Venous Thrombosis

2016
Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
    Thrombosis research, 2008, Volume: 123, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Thrombin; Thrombomodulin; Venous Thrombosis

2008
Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008, Volume: 19, Issue:5

    Topics: Acute Disease; Adult; Aged; Blood Coagulation; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Monitoring, Physiologic; Thrombelastography; Venous Thrombosis

2008
A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008, Volume: 19, Issue:7

    Topics: Afibrinogenemia; Amino Acid Sequence; Amino Acid Substitution; Child, Preschool; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Mutation, Missense; Venous Thrombosis

2008
Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:5

    Topics: Adult; Cohort Studies; Erythrocyte Transfusion; Female; Fibrinogen; Hemostatics; Humans; Platelet Transfusion; Postpartum Hemorrhage; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis; Young Adult

2008
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
    Journal of pediatric surgery, 2008, Volume: 43, Issue:12

    Topics: Blood Component Transfusion; Critical Care; Critical Illness; Factor VIIa; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant; Male; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Venous Thrombosis

2008
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
    Thrombosis and haemostasis, 2008, Volume: 100, Issue:6

    Topics: Adult; Budd-Chiari Syndrome; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Patient Selection; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Risk Assessment; Splanchnic Circulation; Thrombolytic Therapy; Treatment Outcome; Vascular Patency; Venous Thrombosis

2008
Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies.
    Blood, 2009, Aug-27, Volume: 114, Issue:9

    Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Factor V; Family Health; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Infant; Male; Thromboembolism; Thrombosis; Venous Thrombosis

2009
Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report.
    Polskie Archiwum Medycyny Wewnetrznej, 2009, Volume: 119, Issue:12

    Topics: Adult; Contraceptives, Oral; Factor V; Factor XIII; Female; Femoral Vein; Fibrinogen; Genetic Carrier Screening; Humans; Iliac Vein; Point Mutation; Polymorphism, Genetic; Ultrasonography; Venous Thrombosis

2009
Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.
    Thrombosis research, 1983, Aug-01, Volume: 31, Issue:3

    Topics: Abdomen; Adult; Aged; Aged, 80 and over; Anabolic Agents; Androgens; Biomarkers; Blood Viscosity; Case-Control Studies; Elective Surgical Procedures; Female; Fibrinogen; Fibrinolysis; Humans; Injections, Intramuscular; Liver Function Tests; Male; Middle Aged; Plasminogen; Plasminogen Activators; Postoperative Complications; Preoperative Care; Stanozolol; Time Factors; Venous Thrombosis

1983
Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.
    PloS one, 2010, Apr-29, Volume: 5, Issue:4

    Topics: Animals; Blood Platelets; Calcium Signaling; Factor Xa; Fibrin; Fibrinogen; Humans; Mice; Perfusion; Phosphatidylserines; Platelet Aggregation; Protein Binding; Thrombin; Thromboplastin; Venous Thrombosis

2010
[Correlation of inflammatory marker and coagulation factors with deep vein thrombosis].
    Zhongguo shi yan xue ye xue za zhi, 2010, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; C-Reactive Protein; Case-Control Studies; Factor IX; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Venous Thrombosis; Young Adult

2010
Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
    Journal of vascular and interventional radiology : JVIR, 2010, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Combined Modality Therapy; Down-Regulation; Drug Administration Schedule; Female; Fibrinogen; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Middle Aged; Peripheral Vascular Diseases; Radiography; Retrospective Studies; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonic Therapy; Vascular Patency; Venous Thrombosis; Washington; Young Adult

2010
Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:6

    Topics: Animals; Collagen Type IV; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Interferon-gamma; Interleukin-1beta; Leukocytes; Ligation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator; Vena Cava, Inferior; Venous Thrombosis

2010
Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antithrombin III; Blood Coagulation; Calcium-Binding Proteins; Collagen; Cytokines; Disease Models, Animal; Fibrinogen; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myeloid Differentiation Factor 88; Neutrophils; Oligodeoxyribonucleotides; Peptide Hydrolases; Signal Transduction; Th1 Cells; Thrombelastography; Time Factors; Toll-Like Receptor 9; Venous Thrombosis

2011
Dielectric coagulometry: a new approach to estimate venous thrombosis risk.
    Analytical chemistry, 2010, Dec-01, Volume: 82, Issue:23

    Topics: Animals; Blood Coagulation; Cattle; Dielectric Spectroscopy; Erythrocytes; Fibrinogen; Horses; Humans; Models, Theoretical; Rabbits; Rheology; Risk Factors; Thrombin; Venous Thrombosis

2010
Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis.
    Sao Paulo medical journal = Revista paulista de medicina, 2010, Volume: 128, Issue:5

    Topics: Activated Protein C Resistance; Adult; Biomarkers; Epidemiologic Methods; Female; Fibrinogen; Humans; India; Male; Middle Aged; Popliteal Vein; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis; Young Adult

2010
Subclinical activation of coagulation and fibrinolysis in laparoscopic cholecystectomy: do risk factors exist?
    International journal of surgery (London, England), 2011, Volume: 9, Issue:5

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Blood Coagulation; Blood Coagulation Tests; Cholecystectomy, Laparoscopic; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Postoperative Complications; Risk Factors; Sex Factors; Venous Thrombosis

2011
[Venous thrombosis as a complication of pacemaker implantation--own observations].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2011, Volume: 30, Issue:176

    Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Pacemaker, Artificial; Plasminogen Activator Inhibitor 1; Prosthesis Implantation; Recurrence; Risk Factors; Smoking; Stroke Volume; Venous Thrombosis

2011
Rare deletion from the fibrinogen Bβ gene in a patient with a provoked venous thrombotic event.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:7

    Topics: Adult; Afibrinogenemia; Chromatography, Reverse-Phase; DNA Mutational Analysis; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Phenotype; Sequence Deletion; Venous Thrombosis; White People

2011
Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
    Kardiologia polska, 2012, Volume: 70, Issue:3

    Topics: Aged; Biomarkers; C-Reactive Protein; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Incidence; Interleukin-6; Male; Middle Aged; Pacemaker, Artificial; Plasminogen Activator Inhibitor 1; Risk Factors; ROC Curve; Thromboplastin; Time Factors; Venous Thrombosis

2012
Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform.
    Thrombosis research, 2012, Volume: 130, Issue:3

    Topics: Adult; Aged; Apoprotein(a); Female; Fibrin Clot Lysis Time; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Protein Isoforms; Reproducibility of Results; Sensitivity and Specificity; Venous Thrombosis

2012
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:9

    Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Gas Analysis; Blood Platelets; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Green Fluorescent Proteins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Organometallic Compounds; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Solubility; Thrombosis; Time Factors; Venous Thrombosis; Water

2012
Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure.
    European journal of internal medicine, 2012, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Anticoagulants; Biomarkers; Echocardiography; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Stroke Volume; Tissue Plasminogen Activator; Venous Thrombosis; Ventricular Function, Left

2012
A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis.
    International journal of hematology, 2012, Volume: 96, Issue:4

    Topics: Aged; Cerebral Hemorrhage; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Plasmapheresis; Platelet Count; Thrombocytopenia; Thrombosis; Venous Thrombosis

2012
Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; False Positive Reactions; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Proteolysis; ROC Curve; Venous Thrombosis

2013
Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Animals; Blotting, Western; Disease Models, Animal; Drug Carriers; Endothelial Cells; Fibrinogen; Fibrinolytic Agents; Gene Expression Regulation; Iliac Vein; Immunohistochemistry; Injections, Intravenous; Ligation; Lipids; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microbubbles; Nitric Oxide; Nitric Oxide Synthase Type III; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thrombin Time; Thrombomodulin; Time Factors; Vascular Cell Adhesion Molecule-1; Vena Cava, Inferior; Venous Thrombosis

2013
Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis.
    American journal of respiratory and critical care medicine, 2013, Feb-01, Volume: 187, Issue:3

    Topics: Aged; Biomarkers; Denmark; Female; Fibrinogen; Humans; Male; Middle Aged; Odds Ratio; Pulmonary Embolism; Risk Factors; Venous Thrombosis

2013
Parameters predicting complications in flap surgery.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 115, Issue:5

    Topics: Activated Protein C Resistance; Blood Coagulation Tests; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Forecasting; Free Tissue Flaps; Hematologic Tests; Hemorrhagic Disorders; Humans; Male; Necrosis; Plastic Surgery Procedures; Platelet Function Tests; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Reoperation; Skin Transplantation; Surgical Flaps; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor

2013
Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis.
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:3

    Topics: Alleles; Case-Control Studies; Cohort Studies; Female; Fibrinogen; Fibrinogens, Abnormal; Genotype; Haplotypes; Humans; Liver Diseases; Male; Polymorphism, Single Nucleotide; Portal Vein; Venous Thrombosis

2013
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism.
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:3

    Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Tests; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Pulmonary Embolism; Risk Factors; Venous Thrombosis

2013
Thrombosis in association with a novel substitution (γ346Gly→Val) at an absolutely conserved site in the fibrinogen γ chain.
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:4

    Topics: Blood Coagulation; Blood Coagulation Tests; Conserved Sequence; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Mutation; Peptide Fragments; Phenotype; Venous Thrombosis; Young Adult

2013
Does plasma fibrinogen increase thrombotic tendency?
    European journal of clinical investigation, 2002, Volume: 32, Issue:10

    Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk; Venous Thrombosis

2002
G-455A polymorphism of the fibrinogen beta gene and deep vein thrombosis.
    European journal of clinical investigation, 2002, Volume: 32, Issue:10

    Topics: Alleles; Case-Control Studies; Fibrinogen; Genes, APC; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Polymorphism, Genetic; Risk Factors; Venous Thrombosis

2002
Blood rheology in deep venous thrombosis--relation to persistent and transient risk factors.
    Thrombosis research, 2002, Aug-15, Volume: 107, Issue:3-4

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Viscosity; Case-Control Studies; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Hematologic Tests; Hemorheology; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Time Factors; Venous Thrombosis

2002
Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia.
    British journal of haematology, 2002, Volume: 119, Issue:4

    Topics: Adult; Circadian Rhythm; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Plasminogen Activator Inhibitor 1; Quadriplegia; Risk Factors; Spinal Cord Injuries; Venous Thrombosis

2002
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
    The American journal of medicine, 2002, Dec-01, Volume: 113, Issue:8

    Topics: Aged; Biomarkers; Blood Coagulation Factors; C-Reactive Protein; Cohort Studies; Confidence Intervals; Factor VII; Female; Fibrinogen; Humans; Inflammation Mediators; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thromboembolism; Venous Thrombosis; von Willebrand Factor

2002
[Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Przeglad lekarski, 2002, Volume: 59, Issue:7

    Topics: Aged; alpha-2-Antiplasmin; Antithrombins; Arthroplasty, Replacement, Hip; Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemodilution; Humans; Male; Middle Aged; Prothrombin; Thrombin; Thromboembolism; Time Factors; Venous Thrombosis

2002
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.
    Thrombosis and haemostasis, 2003, Volume: 89, Issue:3

    Topics: Adolescent; Adult; Blood Coagulation Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Factor IX; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Obesity; Risk Factors; Venous Thrombosis

2003
Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.
    Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:4

    Topics: Adult; Arterial Occlusive Diseases; DNA Mutational Analysis; DNA Primers; Factor V; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Prothrombin; Thromboembolism; Venous Thrombosis

2003
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster.
    British journal of haematology, 2003, Volume: 121, Issue:4

    Topics: Adolescent; Adult; Aged; DNA; Factor V; Female; Fibrinogen; Genotype; Heterozygote; Humans; Male; Middle Aged; Mutation; Polymorphism, Genetic; Thrombophilia; Venous Thrombosis

2003
Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:6

    Topics: Adolescent; Antineoplastic Agents; Antithrombin III; Asparaginase; Brain; Brain Diseases; Cerebral Hemorrhage; Child; Female; Fibrinogen; Headache; Humans; Magnetic Resonance Imaging; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures; Venous Thrombosis

2003
Global fibrinolytic capacity in colorectal cancer: a new clue to occult fibrinolysis.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2003, Volume: 9, Issue:2

    Topics: Aprotinin; Colonic Neoplasms; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Male; Postoperative Complications; Postoperative Period; Prothrombin Time; Rectal Neoplasms; Risk; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis

2003
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
    Journal of vascular and interventional radiology : JVIR, 2003, Volume: 14, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Disease-Free Survival; Drug Therapy, Combination; Eptifibatide; Female; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hematocrit; Hemoglobins; Hemorrhage; Humans; Iliac Artery; Iliac Vein; Lower Extremity; Male; Middle Aged; Missouri; Peptides; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Prospective Studies; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis

2003
Inhibition of tissue factor limits the growth of venous thrombus in the rabbit.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Blood Vessel Prosthesis; Fibrinogen; Immunohistochemistry; Jugular Veins; Leukocytes; Naphthalenes; Piperidines; Rabbits; Thromboplastin; Venous Thrombosis

2003
[Evaluation of selected parameters of blood coagulation and fibrinolysis system in patients undergoing total hip replacement surgery with normovolemic hemodilution procedure and standard enoxaparine prophylaxis].
    Chirurgia narzadow ruchu i ortopedia polska, 2003, Volume: 68, Issue:2

    Topics: Aged; alpha-2-Antiplasmin; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Blood Coagulation; Blood Coagulation Factors; Enoxaparin; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemodilution; Humans; Male; Middle Aged; Primary Prevention; Prothrombin; Thrombin; Thromboembolism; Time Factors; Venous Thrombosis

2003
Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:8

    Topics: Acute Disease; alpha-2-Antiplasmin; Animals; Bleeding Time; Fibrinogen; Jugular Veins; Lung; Mice; Mice, Transgenic; Pulmonary Embolism; Time Factors; Tissue Plasminogen Activator; Venous Thrombosis

2003
[Significance of fibrinogen B and its role in postoperative venous thrombosis].
    Archivio italiano di chirurgia, 1953, Volume: 77, Issue:2

    Topics: Coagulants; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thrombosis

1953
External measurement of fibrinogen uptake in experimental venous thrombosis and other local pathological states.
    British journal of experimental pathology, 1962, Volume: 43

    Topics: Autoradiography; Coagulants; Fibrinogen; Humans; Iodine; Iodine Radioisotopes; Thrombosis; Venous Thrombosis

1962
EARLY DETECTION OF DEEP VENOUS THROMBOSIS URING IODINE-131 TAGGED FIBRINOGEN.
    Surgical forum, 1963, Volume: 14

    Topics: Coagulants; Diagnosis; Dogs; Fibrinogen; Iodine; Iodine Isotopes; Radioisotopes; Research; Thrombophlebitis; Venous Thrombosis

1963
EARLY DETECTION OF DEEP VENOUS THROMBOSIS DURING IODINE-131 TAGGED FIBRINOGEN.
    Surgical forum, 1963, Volume: 14

    Topics: Coagulants; Diagnosis; Dogs; Fibrinogen; Iodine; Iodine Isotopes; Radioisotopes; Research; Thrombophlebitis; Venous Thrombosis

1963
THE EARLY DETECTION OF DEEP VENOUS THROMBOSIS USING I131-TAGGED HUMAN FIBRINOGEN.
    Canadian journal of surgery. Journal canadien de chirurgie, 1964, Volume: 7

    Topics: Angiography; Dogs; Femoral Vein; Fibrinogen; Geriatrics; Humans; Iodine Isotopes; Radiometry; Research; Serum Albumin; Thrombophlebitis; Vascular Surgical Procedures; Venous Thrombosis

1964
Detection of venous thrombosis with 131 I-labelled fibrinogen in the rabbit.
    Lancet (London, England), 1960, Jul-16, Volume: 2, Issue:7142

    Topics: Animals; Fibrinogen; Rabbits; Radiometry; Thrombosis; Venous Thrombosis

1960
[Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
    Polskie Archiwum Medycyny Wewnetrznej, 2003, Volume: 109, Issue:6

    Topics: Activated Protein C Resistance; DNA Primers; Factor V; Female; Fibrinogen; Humans; Male; Middle Aged; Point Mutation; Venous Thrombosis

2003
Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes.
    Thrombosis and haemostasis, 2003, Volume: 90, Issue:5

    Topics: Adult; Fibrinogen; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Orthopedic Procedures; Venous Thrombosis; von Willebrand Diseases

2003
High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:12

    Topics: Adolescent; Adult; Age Factors; Aged; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Risk; Venous Thrombosis

2003
Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation.
    British journal of haematology, 2004, Volume: 125, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antithrombins; beta-Thromboglobulin; Factor XI; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Phosphorylation; Platelet Activation; Thrombosis; Venous Thrombosis

2004
Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Activated Protein C Resistance; Adult; Antigens; Antithrombin III; Behcet Syndrome; Cross-Sectional Studies; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Protein C; Protein S; Ristocetin; Thrombophilia; Venous Thrombosis; von Willebrand Factor

2004
P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Journal of the American College of Surgeons, 2004, Volume: 199, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Blood Platelets; Cohort Studies; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; P-Selectin; Platelet Factor 4; Prospective Studies; Thrombocytopenia; Thromboembolism; Vascular Diseases; Venous Thrombosis

2004
Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies.
    American journal of hematology, 2004, Volume: 76, Issue:3

    Topics: Afibrinogenemia; Factor VIII; Female; Fibrinogen; Humans; Kidney; Ovary; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Recurrence; Venous Thrombosis; von Willebrand Factor

2004
Mesenteric venous thrombosis in a patient with congenital afibrinogenemia and diffuse peritonitis.
    Annals of hematology, 2005, Volume: 84, Issue:2

    Topics: Adult; Afibrinogenemia; Fibrinogen; Humans; Male; Mesenteric Vascular Occlusion; Perioperative Care; Peritonitis; Venous Thrombosis

2005
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:6

    Topics: Aged; Alleles; Body Mass Index; Case-Control Studies; Environment; Europe; Exons; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Interleukin-6; Introns; Male; Middle Aged; Models, Genetic; Myocardial Infarction; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Regression Analysis; Reverse Transcriptase Polymerase Chain Reaction; Risk; Smoking; Time Factors; Venous Thrombosis

2004
Usefulness of the D-dimer/fibrinogen ratio to predict deep venous thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Venous Thrombosis

2005
No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2005, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Genetic Testing; Humans; Male; Middle Aged; Polymorphism, Genetic; Pulmonary Embolism; Venous Thrombosis

2005
Haemorheological alterations in Behçet's disease are not related to a tendency for venous thrombosis.
    Thrombosis research, 2005, Volume: 115, Issue:5

    Topics: Adult; Behcet Syndrome; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Risk Factors; Venous Thrombosis

2005
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:5

    Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Case-Control Studies; Cross-Linking Reagents; Factor XIII; Female; Fibrinogen; Gene Frequency; Heterozygote; Homozygote; Humans; Leucine; Male; Middle Aged; Mutation; Odds Ratio; Risk; Valine; Venous Thrombosis

2005
An animal model for venous thrombosis and spontaneous pulmonary embolism.
    Spinal cord, 2005, Volume: 43, Issue:11

    Topics: Animals; Autoradiography; Blood Coagulation Factors; Body Weight; Disease Models, Animal; Dogs; Fibrinogen; Humans; Iodine Isotopes; Lung; Platelet Aggregation; Pulmonary Embolism; Radiography; Sodium Morrhuate; Staining and Labeling; Thromboembolism; Time Factors; Tissue Distribution; Venous Thrombosis

2005
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor.
    Blood, 2005, Oct-01, Volume: 106, Issue:7

    Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Coagulation; Complement C3; Complement C5; Complement C9; Complement System Proteins; Endothelium, Vascular; Escherichia coli; Female; Fibrinogen; Glycoproteins; Humans; Immunoglobulin G; Inflammation; Lipopolysaccharides; Male; Microscopy, Fluorescence; Protein Structure, Tertiary; Rats; Rats, Wistar; Thrombosis; Time Factors; Venous Thrombosis

2005
[Thrombosis of the renal veins in a premature infant. Treatment with heparin and urokinase].
    Annales de pediatrie, 1976, Feb-02, Volume: 23, Issue:2

    Topics: Acute Disease; Anticoagulants; Combined Modality Therapy; Cyanosis; Dehydration; Diarrhea, Infantile; Dyspnea; Factor V; Factor VII; Factor X; Female; Fibrinogen; Follow-Up Studies; Heparin; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Peritoneal Dialysis; Plasminogen; Renal Veins; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thrombosis

1976
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.
    Blood, 2005, Dec-15, Volume: 106, Issue:13

    Topics: Adolescent; Adult; Aged; Base Sequence; Fibrinogen; Genetic Variation; Haplotypes; Humans; Middle Aged; Risk Factors; Venous Thrombosis

2005
Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.
    Human genetics, 2006, Volume: 119, Issue:1-2

    Topics: Adult; Aged; Alleles; Cell Line, Tumor; DNA Mutational Analysis; Female; Fibrinogen; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Luciferases; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic; Protein Subunits; Recombinant Fusion Proteins; Taiwan; Thromboembolism; Venous Thrombosis

2006
[Fibrinogen-guided thrombolysis with urokinase of a portal and mesenterial venous thrombosis during an acute episode of ulcerative colitis].
    Deutsche medizinische Wochenschrift (1946), 2006, Jan-20, Volume: 131, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Diarrhea; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Heparin; Humans; Magnetic Resonance Imaging; Mesenteric Veins; Portal Vein; Prednisolone; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Venous Thrombosis

2006
Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:2

    Topics: Adult; Anticoagulants; Female; Fibrinogen; Humans; Male; Middle Aged; Protein C; Reference Values; Risk Factors; Venous Thrombosis

2006
A late complication of thrombosis in internal jugular vein and subclavian vein in a pregnant woman with ovarian hyperstimulation syndrome.
    Acta obstetricia et gynecologica Scandinavica, 2006, Volume: 85, Issue:1

    Topics: Abortion, Induced; Adult; Anticoagulants; Antithrombin III; Embryo Transfer; Female; Fertilization in Vitro; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Jugular Veins; Ovarian Hyperstimulation Syndrome; Pleural Effusion; Pregnancy; Pregnancy Complications, Hematologic; Subclavian Vein; Venous Thrombosis; Warfarin

2006
Coagulation parameters after retransfusion of unwashed blood.
    The Journal of arthroplasty, 2006, Volume: 21, Issue:3

    Topics: Aged, 80 and over; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Blood Transfusion, Autologous; Estrogen Replacement Therapy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Filtration; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Retreatment; Time Factors; Venous Thrombosis

2006
Pediatric reference intervals for uncommon bleeding and thrombotic disorders.
    The Journal of pediatrics, 2006, Volume: 149, Issue:2

    Topics: Adolescent; alpha-2-Antiplasmin; Antithrombins; Blood Coagulation Disorders; Child; Factor V; Factor VII; Factor X; Fibrinogen; Humans; Pediatrics; Plasminogen; Protein C; Protein S; Prothrombin; Reference Values; Venous Thrombosis

2006
A Bbeta 14 Arg --> Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III).
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:12

    Topics: Adult; Arginine; Cysteine; Fibrinogen; Heterozygote; Humans; Male; Mutation; Pedigree; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis

2006
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Thrombosis and haemostasis, 2006, Volume: 96, Issue:4

    Topics: Arterial Occlusive Diseases; Blood Coagulation Factors; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Germany; Humans; Integrin alpha2; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Serine Endopeptidases; Thromboembolism; Thrombophilia; Tissue Plasminogen Activator; Venous Thrombosis

2006
Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis.
    Thrombosis research, 2007, Volume: 120, Issue:5

    Topics: Adolescent; Adult; Aged; Antithrombins; Blood Coagulation; Case-Control Studies; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fibrinogen; Genotype; Hormone Replacement Therapy; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein C; Protein S; Venous Thrombosis

2007
[Thrombosis of the inferior vena cava and the iliac and femoral veins in a 24-year old man].
    Deutsche medizinische Wochenschrift (1946), 2007, Jan-05, Volume: 132, Issue:1-2

    Topics: Adult; Anticoagulants; Factor V; Femoral Vein; Fibrinogen; Heterozygote; Humans; Iliac Vein; Male; Mutation; Phenprocoumon; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex; Vena Cava, Inferior; Venous Thrombosis

2007
[A component of earthworm fibrinolytic enzyme having higher thrombolytic activity than total components in vivo].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2006, Volume: 41, Issue:11

    Topics: Amino Acid Sequence; Animals; Bleeding Time; Dogs; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Fibrinolytic Agents; Lethal Dose 50; Male; Mice; Molecular Sequence Data; Molecular Weight; Oligochaeta; Rats; Rats, Wistar; Sequence Analysis, Protein; Spectrophotometry, Infrared; Venous Thrombosis

2006
Fibrinogen metabolism in patients with spinal cord injury.
    The journal of spinal cord medicine, 2006, Volume: 29, Issue:5

    Topics: Acute Disease; Adult; Case-Control Studies; Chronic Disease; Disease Progression; Fibrin; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Male; Middle Aged; Paralysis; Pulmonary Embolism; Risk Factors; Spinal Cord Injuries; Time Factors; Venous Thrombosis

2006
Late results of catheter-directed recombinant tissue plasminogen activator fibrinolytic therapy of iliofemoral deep venous thrombosis.
    Clinics (Sao Paulo, Brazil), 2007, Volume: 62, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Catheterization, Peripheral; Epidemiologic Methods; Female; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Humans; Iliac Vein; Male; Middle Aged; Postphlebitic Syndrome; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency; Venous Thrombosis

2007
Venous thromboembolism--a manifestation of the metabolic syndrome.
    Haematologica, 2007, Volume: 92, Issue:3

    Topics: Adult; Aged; Austria; Blood Glucose; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cytokines; Factor VIII; Female; Fibrinogen; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Prospective Studies; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophilia; Triglycerides; Venous Thrombosis; Waist-Hip Ratio

2007
Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma'/gammaA mRNA ratio.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:6

    Topics: Base Sequence; Cell Line; DNA Primers; Fibrinogen; Haplotypes; Humans; In Vitro Techniques; Mutagenesis, Site-Directed; Peptide Fragments; Polymorphism, Single Nucleotide; Recombinant Proteins; RNA Precursors; RNA Processing, Post-Transcriptional; RNA, Messenger; Sequence Deletion; Transcription, Genetic; Transfection; Venous Thrombosis

2007
Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Homozygote; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Introns; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Receptors, Interleukin-1 Type I; Receptors, Interleukin-1 Type II; Risk Assessment; Risk Factors; Venous Thrombosis

2007
The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
    Thrombosis research, 2007, Volume: 121, Issue:1

    Topics: Adult; Aged; Austria; Case-Control Studies; DNA Mutational Analysis; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis

2007
Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
    Thrombosis research, 2007, Volume: 121, Issue:3

    Topics: Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Base Sequence; Deoxyribonucleases, Type II Site-Specific; DNA Primers; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Venous Thrombosis

2007
Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:3

    Topics: Adult; Blood Viscosity; Body Mass Index; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Triglycerides; Venous Thrombosis

2007
Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:3

    Topics: Adult; Case-Control Studies; DNA Mutational Analysis; Factor XII; Female; Fibrinogen; Hemostasis; Humans; Integrin beta3; Janus Kinase 2; Male; Philadelphia Chromosome; Polycythemia Vera; Polymorphism, Genetic; Risk Assessment; Risk Factors; Thrombocythemia, Essential; Venous Thrombosis

2007
Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Thrombosis research, 2008, Volume: 121, Issue:6

    Topics: Adult; Amino Acid Substitution; Calcium; Catalysis; Electrophoresis, Polyacrylamide Gel; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Humans; Ions; Microscopy, Electron, Scanning; Polymerase Chain Reaction; Postpartum Period; Solubility; Surface Properties; Thrombin; Thrombophilia; Time Factors; Tissue Plasminogen Activator; Venous Thrombosis

2008
Prevalence of deep vein thrombosis (DVT) in non-surgical patients at hospital admission.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:4

    Topics: Aged; C-Reactive Protein; Dimerization; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospitalization; Humans; Male; Middle Aged; Prevalence; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Venous Thrombosis

2007
Fibrinogen concentration and factor VIII activity in women with preeclampsia.
    Hypertension in pregnancy, 2007, Volume: 26, Issue:4

    Topics: Abortion, Threatened; Cholestasis; Factor VIII; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Venous Thrombosis

2007
Alcohol consumption is associated with a decreased risk of venous thrombosis.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:1

    Topics: Adult; Aged; Alcohol Drinking; Case-Control Studies; Down-Regulation; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Netherlands; Odds Ratio; Pulmonary Embolism; Risk Assessment; Risk Factors; Sex Factors; Surveys and Questionnaires; Venous Thrombosis; von Willebrand Factor

2008
Postoperative deep venous thrombosis in a woman with congenital afibrinogenaemia treated with fibrinogen concentrates.
    European journal of anaesthesiology, 2008, Volume: 25, Issue:6

    Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Eye Enucleation; Female; Fibrinogen; Humans; Postoperative Complications; Treatment Outcome; Ultrasonography; Venous Thrombosis

2008
Thrombolytic effect after sequential double-bolus administration of tissue plasminogen activator and urokinase-fibrinogen conjugate into dogs with venous thrombosis.
    Annals of the New York Academy of Sciences, 1998, Dec-13, Volume: 864

    Topics: Animals; Dogs; Drug Therapy, Combination; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Injections, Intravenous; Recombinant Proteins; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Venous Thrombosis

1998
Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model.
    Glycoconjugate journal, 1998, Volume: 15, Issue:9

    Topics: Animals; Blood Coagulation; Calcium Chloride; Disease Models, Animal; Factor XII; Fibrinogen; Gangliosides; Kinetics; Male; Protein Binding; Prothrombin Time; Rats; Rats, Sprague-Dawley; Sulfoglycosphingolipids; Venous Thrombosis

1998
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis.
    Thrombosis research, 1999, Jan-01, Volume: 93, Issue:1

    Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fibrinogen; Fibrinolytic Agents; Male; Platelet Count; Rats; Rats, Wistar; Thrombosis; Venous Thrombosis

1999
Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:4

    Topics: Factor V; Fibrinogen; Humans; Point Mutation; Risk Factors; Venous Thrombosis

1999
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:5

    Topics: Acute-Phase Reaction; Adult; Aged; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Venous Thrombosis

1999
Selective venous thrombolysis with the nipple-balloon catheter: comparative evaluation in vivo.
    Journal of vascular and interventional radiology : JVIR, 1999, Volume: 10, Issue:6

    Topics: Animals; Anticoagulants; Catheterization; Contrast Media; Coronary Vessels; Disease Models, Animal; Drug Delivery Systems; Equipment Design; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Heparin; Hindlimb; Iliac Vein; Iodine; Ioxaglic Acid; Partial Thromboplastin Time; Pulmonary Embolism; Spectrometry, X-Ray Emission; Swine; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis

1999
[The influence of the intra-tissue electrical phonophoresis on the hemostasis system in the treatment of acute thrombophlebitis and phlebothrombosis].
    Klinichna khirurhiia, 1999, Issue:5

    Topics: Acute Disease; Adult; Blood Coagulation; Cell Adhesion Molecules; Electric Stimulation; Female; Fibrinogen; Homeostasis; Humans; Male; Middle Aged; Phonophoresis; Thrombophlebitis; Venous Thrombosis

1999
Evaluation of markers of deep vein thrombosis in patients undergoing surgery for maxillofacial malignancies.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 1999, Volume: 27, Issue:4

    Topics: Antithrombin III; Blood Coagulation Tests; Case-Control Studies; Factor XIIa; Fibrinogen; Head and Neck Neoplasms; Humans; Kallikrein-Kinin System; Monitoring, Intraoperative; Multivariate Analysis; Peptide Hydrolases; Postoperative Complications; Thromboembolism; Tissue Plasminogen Activator; Venous Thrombosis

1999
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.
    Blood, 2000, May-01, Volume: 95, Issue:9

    Topics: Adult; Age Factors; Aged; Antithrombins; Biomarkers; Carboxypeptidase B2; Carboxypeptidases; Case-Control Studies; Contraceptives, Oral; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Protein C; Prothrombin; Reference Values; Regression Analysis; Venous Thrombosis

2000
An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Thrombosis research, 2000, May-15, Volume: 98, Issue:4

    Topics: alpha-2-Antiplasmin; Animals; Carboxypeptidase B2; Carboxypeptidases; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Drug Synergism; Endothelium, Vascular; Enzyme Activation; Fibrin; Fibrinogen; Fibrinolysis; Infusions, Intravenous; Plant Proteins; Plasminogen; Protease Inhibitors; Rabbits; Solanum tuberosum; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator; Venous Thrombosis

2000
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    Clinical hemorheology and microcirculation, 2000, Volume: 22, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Viscosity; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cohort Studies; Disease Progression; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Germany; Hematocrit; Hemorheology; Humans; Life Tables; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prospective Studies; Risk Factors; Survival Analysis; Thrombophilia; Uterine Cervical Neoplasms; Uterine Neoplasms; Venous Thrombosis

2000
alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
    Blood, 2000, Aug-01, Volume: 96, Issue:3

    Topics: Fibrinogen; Humans; Polymorphism, Genetic; Venous Thrombosis

2000
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
    Journal of clinical epidemiology, 2000, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Black People; Case-Control Studies; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Regression Analysis; Risk Factors; United States; Venous Thrombosis

2000
Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2001, Volume: 12, Issue:7

    Topics: alpha-2-Antiplasmin; Animals; Anticoagulants; Arthropod Venoms; Disease Models, Animal; Factor XIII; Female; Fibrinogen; Fibrinolytic Agents; Infusions, Intravenous; Injections, Intravenous; Jugular Veins; Male; Plasminogen; Rabbits; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Venous Thrombosis

2001
Human thrombi contain an abundance of active thrombin.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:4

    Topics: Antithrombin III; Blotting, Western; Chromogenic Compounds; Dipeptides; Enzyme-Linked Immunosorbent Assay; Fibrin; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Prothrombin; Pulmonary Embolism; Thrombin; Venous Thrombosis

2001
Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.
    European heart journal, 2001, Volume: 22, Issue:24

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Coronary Artery Disease; DNA Primers; Fibrinogen; Genotype; Germany; Humans; Male; Massachusetts; Middle Aged; Mutation; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Stroke; Venous Thrombosis; White People

2001
Weight-based rt-PA thrombolysis protocol for acute native arterial and bypass graft occlusions.
    Journal of vascular and interventional radiology : JVIR, 2002, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Body Weight; Catheterization, Peripheral; Child; Child, Preschool; Fibrinogen; Graft Occlusion, Vascular; Hematocrit; Humans; Infant; Middle Aged; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis

2002
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
    Haematologica, 2002, Volume: 87, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Child; Drug Resistance; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Prothrombin; Recurrence; Risk Factors; Thrombophilia; Venous Thrombosis

2002
Biological risk factors for deep vein trombosis.
    Clinical hemorheology and microcirculation, 2002, Volume: 26, Issue:1

    Topics: Biomarkers; Blood Glucose; Blood Viscosity; Case-Control Studies; Cholesterol; Erythrocyte Aggregation; Fibrinogen; Hematocrit; Humans; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; Venous Thrombosis

2002
[Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1998, Volume: 33, Issue:7

    Topics: Animals; Endopeptidases; Female; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Male; Plasminogen; Rats; Rats, Wistar; Streptomyces; Venous Thrombosis

1998
An experimental clot model in sheep; generation of a heterologous clot and its detection in vivo using venography and (125)I labelled fibrinogen.
    Research in veterinary science, 2002, Volume: 72, Issue:3

    Topics: Animals; Blood Coagulation; Cattle; Fibrinogen; Humans; Iodine Radioisotopes; Phlebography; Saphenous Vein; Sheep; Sheep Diseases; Venous Thrombosis

2002
Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors.
    British journal of haematology, 2002, Volume: 118, Issue:1

    Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Risk Factors; Sex Factors; Triglycerides; Venous Thrombosis

2002